Notwithstanding the preliminary value and the limitations of the study, the “targeted gene” panel used here might allow to increase the number of potentially dementia-related variants and to extend the clinical features associated with genetic variants described in the TREM2, CHMP2B, APP, and GRN genes. The gene discussed is TREM2; the disease is dementia.